GABRG2 rs6449213: What Your Genotype Means
The rs6449213 variant is a genetic marker located within the GABRG2 gene, which plays a critical role in brain signaling. Research associates this variant with altered GABAergic pathways and potential susceptibility to various epilepsy syndromes.
What each genotype means
Typical GABRG2 variant profile
This genotype represents the common version of this genetic marker. Research into GABRG2 focuses primarily on rare, pathogenic mutations that disrupt GABAergic signaling and increase epilepsy susceptibility, rather than common variations like this one. You should not interpret this result as an indicator of epilepsy risk.
This is the most common genotype observed across global populations.
Typical GABRG2 variant profile
This genotype represents a common version of this genetic marker. While the GABRG2 gene is known to harbor rare, high-impact mutations linked to seizure disorders, this specific common variation is not established as a clinical risk factor. It is considered a standard genetic variation found in the general population.
This genotype is frequently observed in many populations worldwide.
Typical GABRG2 variant profile
This genotype represents a common version of this genetic marker. Current scientific literature does not associate this specific common variation with altered GABAergic signaling or increased epilepsy risk. The clinical significance of GABRG2 is primarily tied to rare, deleterious mutations rather than common variants.
This is a common genotype found across diverse ancestral groups.
Understanding the rs6449213 Variant
The rs6449213 variant is a single nucleotide polymorphism (SNP) situated within the GABRG2 gene. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. This specific variant is located in a region of the genome that influences the expression or function of the GABRG2 protein. While many SNPs are neutral and have no observable effect on health, researchers study variants like rs6449213 to determine if they contribute to differences in biological processes. By mapping these variations, scientists can better understand the genetic architecture of complex neurological conditions. It is important to note that the presence of a specific SNP does not guarantee the development of a condition; rather, it is one of many factors, including other genetic influences and environmental triggers, that may influence an individual's health profile over time.
The Role of the GABRG2 Gene
The GABRG2 gene provides instructions for creating the gamma-2 subunit of the GABA-A receptor. GABA-A receptors are essential components of the central nervous system, acting as the primary inhibitory neurotransmitter system in the brain. By allowing chloride ions to enter neurons, these receptors help dampen or 'inhibit' excessive electrical activity, maintaining a balanced state of excitability. When the GABRG2 gene functions correctly, it ensures that these receptors are properly assembled and trafficked to the cell surface. Disruptions in this gene can lead to impaired GABAergic signaling, which may lower the threshold for seizures. Because this system is so fundamental to preventing over-excitation in the brain, variations in GABRG2 are frequently investigated in the context of epilepsy and other neurological disorders where the balance of brain activity is disrupted.
Research and Evidence Strength
Current research into GABRG2 has established a clear link between the gene and a spectrum of epilepsy syndromes, ranging from simple febrile seizures to more complex developmental and epileptic encephalopathies. The evidence for rs6449213 specifically is considered moderate, as it is often studied as part of broader genetic association analyses. While some studies suggest that variants in this region may influence susceptibility to seizure disorders by altering receptor sensitivity or expression, the clinical impact of this specific SNP can vary significantly between individuals. It is essential to distinguish between rare, highly penetrant mutations that cause severe disease and common variants like rs6449213, which may only slightly modify risk. Because epilepsy is a multifactorial condition, the presence of this variant should not be interpreted as a diagnostic indicator, but rather as a point of interest in the ongoing study of neurological health.
Population Frequency
The rs6449213 variant is classified as a common variant, meaning it is found at a relatively high frequency across diverse human populations. Because it is common, many individuals carry one or two copies of the variant allele without experiencing any clinical symptoms or neurological conditions. This high prevalence suggests that the variant is not a primary cause of disease on its own, but may instead act as a modifier that interacts with other genetic or environmental factors. Population databases indicate that the distribution of this SNP is widespread, though exact frequencies can fluctuate depending on ancestral background. Understanding that this variant is common helps contextualize its role; it is a normal part of human genetic diversity, and its presence is not inherently indicative of a health issue.
Interpreting Your Genetic Information
If you have received information about your rs6449213 genotype, it is important to approach it with a clear understanding of its limitations. Genetic testing for common variants is not a substitute for professional medical evaluation. Because this variant is common and its association with health outcomes is complex, it cannot be used to predict whether an individual will develop epilepsy or any other condition. If you have concerns about your neurological health or a family history of seizures, the most appropriate step is to consult with a healthcare provider or a genetic counselor. They can help interpret your results in the context of your personal and family medical history. Never make changes to your health regimen or medication based on genetic data without first discussing it with your clinician or pharmacist, as they are best equipped to provide personalized medical guidance.
How common is this variant?
The rs6449213 variant is a common polymorphism found across global populations, with its specific genotype frequencies varying by ancestral background.
Frequently asked questions
Does having the rs6449213 variant mean I will have epilepsy?
No, having this variant does not mean you will develop epilepsy. It is a common genetic marker, and most people who carry it do not have any seizure disorders.
What is the GABRG2 gene responsible for?
The GABRG2 gene encodes a subunit of the GABA-A receptor, which is vital for inhibitory signaling in the brain. This system helps regulate electrical activity and prevents neurons from becoming over-excited.
Should I be worried about my rs6449213 result?
There is no reason for concern based on this result alone. Because this is a common variant, it is considered a normal part of human genetic variation rather than a definitive indicator of disease.
Can I use this information to change my medication?
No. You should never change or stop any medication based on genetic test results. Always consult with your doctor or pharmacist before making any changes to your treatment plan.
Where can I learn more about my genetic risk for epilepsy?
If you are concerned about your risk, you should speak with a medical professional or a genetic counselor. They can review your family history and clinical symptoms to provide accurate, personalized information.
Sources & further reading
Educational information only, last refreshed 9/21/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs6449213?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in GABRG2
This variant in the GABRG2 gene is associated with variations in response to certain anticonvulsant medications and epilepsy susceptibility.
This variant is located in the GABRG2 gene, which encodes the gamma-2 subunit of the GABA-A receptor; variants in this gene are associated with a spectrum of epilepsy syndromes.
Linked to GABA-A receptor subunit dysfunction, a known mechanism for inherited epilepsy syndromes.
A common variant in GABRG2, a gene encoding a GABA-A receptor subunit linked to various epilepsy phenotypes including febrile seizures and GEFS+.
Variant in GABRG2, a gene where mutations can alter GABA-A receptor function and influence seizure thresholds.
Mutations in GABRG2 are linked to a spectrum of epilepsy ranging from simple febrile seizures to severe developmental and epileptic encephalopathies.